<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Poole LG</submitter><funding>National Institute of Environmental Health Sciences</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>U.S. Department of Agriculture</funding><funding>NIEHS NIH HHS</funding><pagination>1182-1192</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9035112</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The blood coagulation factor fibrin(ogen) can modulate inflammation by altering leukocyte activity. Analyses of fibrin(ogen)-mediated proinflammatory activity have largely focused on leukocyte integrin binding activity revealed by conversion of fibrinogen to a stabilized fibrin polymer by blood coagulation enzymes. In addition to coagulation enzymes, fibrinogen is a substrate for tissue transglutaminase-2 (TG2), a widely expressed enzyme that produces unique fibrinogen Aα-γ chain cross-linked products.&lt;h4>Objectives&lt;/h4>We tested the hypothesis that TG2 dependent cross-linking alters the proinflammatory activity of surface-adhered fibrinogen.&lt;h4>Methods&lt;/h4>Mouse bone marrow-derived macrophages (BMDMs) were cultured on tissue culture plates coated with fibrinogen or TG2-</pubmed_abstract><journal>Journal of thrombosis and haemostasis : JTH</journal><pubmed_title>Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.</pubmed_title><pmcid>PMC9035112</pmcid><funding_grant_id>F32DK121423</funding_grant_id><funding_grant_id>K99 DK129710</funding_grant_id><funding_grant_id>K99DK129710</funding_grant_id><funding_grant_id>R01 DK120289</funding_grant_id><funding_grant_id>F32 DK121423</funding_grant_id><funding_grant_id>R01DK120289</funding_grant_id><funding_grant_id>R01DK112778</funding_grant_id><funding_grant_id>R01ES017537</funding_grant_id><funding_grant_id>R01 ES017537</funding_grant_id><pubmed_authors>Flick MJ</pubmed_authors><pubmed_authors>Kopec AK</pubmed_authors><pubmed_authors>Luyendyk JP</pubmed_authors><pubmed_authors>Poole LG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.</name><description>&lt;h4>Background&lt;/h4>The blood coagulation factor fibrin(ogen) can modulate inflammation by altering leukocyte activity. Analyses of fibrin(ogen)-mediated proinflammatory activity have largely focused on leukocyte integrin binding activity revealed by conversion of fibrinogen to a stabilized fibrin polymer by blood coagulation enzymes. In addition to coagulation enzymes, fibrinogen is a substrate for tissue transglutaminase-2 (TG2), a widely expressed enzyme that produces unique fibrinogen Aα-γ chain cross-linked products.&lt;h4>Objectives&lt;/h4>We tested the hypothesis that TG2 dependent cross-linking alters the proinflammatory activity of surface-adhered fibrinogen.&lt;h4>Methods&lt;/h4>Mouse bone marrow-derived macrophages (BMDMs) were cultured on tissue culture plates coated with fibrinogen or TG2-</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-27T04:21:30.653Z</modification><creation>2025-02-19T04:20:56.09Z</creation></dates><accession>S-EPMC9035112</accession><cross_references><pubmed>35158413</pubmed><doi>10.1111/jth.15670</doi></cross_references></HashMap>